Alli hits the market

Alli is now out. The news we have been looking at for months is
here. Alli, which is the over the counter version of Xenical for
loss is now on the market so that people can use this as a aid to
their loss program. I have said for years that you can not trust
any pills to have you lose and I am still a little apprehensive to
recommend that people use Alli to try to lose as the most important
things in your control program are proper eating and exercise. Here
is the press release for the product

Before you go out and buy Alli I just wanted to let you
know that in researching this product I looked for a natural
alternative. I have found one product that does what Alli does but
is natural, cheaper and best of all has no side effects. That
product is called Avatrim. Check out Avatrim before you go out to
purchase Alli.

GlaxoSmithKline Consumer Healthcare announces today that the
U.S. Food and Drug Administration (FDA) approved the -loss product
orlistat 60 mg capsules for over-the-counter (OTC) use in the
United States. GSK Consumer Healthcare will market OTC orlistat
under the brand name alli(TM) (pronounced AL-eye). Approved for use
by over adults in conjunction with a reduced-calorie, low-fat diet,
alli helps people lose 50 percent more than with diet alone. alli
is the only FDA-approved -loss product available to consumers
without a prescription, and it is the first clinically-proven over-
the-counter product to be combined with a comprehensive support
program. alli is expected to be available in stores nationwide by
summer 2007. This approval marks the start of an educational
program that includes a series of resources online at
myalli.com.

GSK Consumer Healthcare selected alli as the brand name because
it conveys the concept of partnership with consumers in their -loss
efforts. Consumers spend billions of dollars each year on fad
diets, unproven miracle pills, and potentially unsafe -loss
supplements that may not work. alli is the clinically proven option
to these hyped, quick-fix products that mislead over adults away
from -loss strategies that are backed by medical science. With
alli, consumers have access to an individually tailored online
action plan that provides support and the necessary tools to help
them lose 50 percent more than with diet alone.

Caroline Apovian, M.D., Director of the Center for Nutrition and
Weight Management at Boston Medical Center welcomed the FDA
decision. “I applaud the alli program for stressing the
importance of a reduced-calorie, low-fat diet in conjunction with a
-loss medicine proven to be safe and effective. This lines up with
research that shows even modest, gradual loss provides significant
health benefits.” Apovian adds, “More and more people each year
— now two-thirds of all American adults — are over or obese and
still gaining weight.

Desperate to lose this excess , people resort to all types of
extreme methods that promise everything and deliver no real
results. Extremely restrictive diets are unrealistic to maintain,
even for a couple of weeks. Dieters end up gaining more than they
initially lost. It’s time consumers readjust their thinking to
realize positive results.”

Why Alli is Different

Unlike other products on store shelves, alli is a proven
medicine with a comprehensive support program. To help consumers
get off to a successful start, the alli package will include
Welcome and Companion Guides, a Guide to Healthy Eating, a Daily
Journal, a Calorie and Fat Counter, Quick Fact Cards, and free
access to an individualized online action plan at myalli.com.

“With Alli, we’re excited to offer a revolutionary approach
to loss,” says Steven L. Burton, Vice President, Weight Control,
GlaxoSmithKline Consumer Healthcare. “alli is more than a pill
— it’s a comprehensive program that works in conjunction with a
sensible diet to increase weight loss. Because loss doesn’t
happen overnight, we’re starting to educate consumers now about
the importance of realistic expectations, gradual loss and
lifestyle changes. That’s the way to see results, and with alli,
we know they can do it.”

Starting today, GSK Consumer Healthcare will gear up production
to have the product ready for shipment and in stores by the summer.
The company is using this period to build awareness and
understanding about the product and its intended user — with the
message — alli is not for everyone. It’s for the committed
consumer who can follow a reduced-calorie, low-fat diet. For this
consumer, alli will provide a unique, proven approach to loss,
offering straight talk, educational tools and an online support
program — myalli.com.

How to Use alli

alli, the only FDA-approved -loss product soon to be available
without a prescription, is indicated for loss in over adults 18
years and older when used along with a reduced-calorie, low-fat
diet. The recommended dose of alli is one 60 mg capsule three times
a day with meals containing fat.

Taken at meal-time, alli works by blocking about 25 percent of
the fat in the food a person eats. Because of the way it works,
alli must be used in conjunction with a reduced-calorie, low-fat
diet containing about 15 grams of fat per meal. The guides and
information supplied in the alli package help the consumer to
control the amount of fat in their meals, and to follow an
appealing, reduced-calorie, low-fat diet. Consuming a meal with too
much fat, while taking alli, can result in bowel changes such as
having an urgent need to use the bathroom. These changes, called
treatment effects, generally occur in the first weeks of treatment,
are not harmful, and can be managed by following the recommended
diet with about 15 grams of fat per meal. Users should take a
multivitamin once a day, at bedtime, because alli can reduce the
absorption of some vitamins.

Safety and Efficacy

alli (60 mg orlistat capsules) is safe and effective when used
as directed. As the most extensively studied -loss medication on
the market, the safety and efficacy of orlistat is very well
established. A higher dose of orlistat has been marketed as the
prescription drug Xenical(R) (orlistat 120 mg capsules) in the U.S.
since 1999 and is supported by nine years of worldwide use in 145
other countries. Orlistat experience in more than 25 million
patient treatments and more than 100 clinical studies with more
than 30,000 patients is unprecedented. One of these studies with
Xenical is the four-year landmark XENDOS trial conducted by Roche,
its inventor and manufacturer. This study is the longest study ever
conducted for a -loss medicine.

Xenical (orlistat 120 mg capsules) will remain available by
prescription for those who should be treated under the care of a
physician. Xenical will continue to be manufactured and sold by
Roche.

For more information on alli, go to myalli.com.

About Over and Obesity
Currently, approximately 65 percent of U.S. adults are over or
obese, according to the National Institutes of Health. Research
suggests that over individuals appear to be on the pathway to
obesity.(i, ii) Over and obesity are associated with an increased
risk of developing health problems such as hypertension, type 2
diabetes and heart disease.(iii) Factors that can contribute to
over include an abundance of high-calorie foods, low levels of
physical activity, behavior, environment, and genetics.(iv)
Multiple studies have shown that a modest reduction in improves
health outcomes significantly in over or obese patients

The post Alli
hits the market
appeared first on Fitness Tips for Life.

Related posts:

  1. Alli
    sells 2 million starter packs – But is it good news?
    I have
    mentioned before that I am not a big fan of Alli and most of the
    trainers and experts…
  2. Xenical competitor
    Alli with Orlistat
    Xenical is a very popular prescription fat
    inhibitor that has been on the market since 1999. Now the company
    that…
  3. Meridia
    Weight Loss Pills pulled off the Market
    A couple years ago my
    wife tried Meridia, a big exercise nut and also perhaps one of the
    few people…

Source: FS – All-FitnessBlogs
Alli hits the market